Daily FNArena News - Australia

A weak interim result and significant balance sheet issues have raised the question of whether Hastie Group is a going concern.

Bad weather impacted on production in the March quarter but brokers continue to see value in BHP Billiton at current levels.

With QRxPharma close to filing for FDA approval for its MoxDuo compound, Southern Cross has upgraded to Buy.

While analysts query Woodside’s expansion schedule, Santos and BHP score downgrades.

A solid third quarter sales result from Woolworths in the face of various issues has brokers looking forward to a continuing recovery.

The March quarter index re-balancing saw PaperlinX removed from the S&P/ASX200 Index, which added a further reason to avoid the stock according to Morningstar.

Bank of Queensland is confident of a swift rebound post-disasters but brokers remain somewhat concerned.

A lot of alpha action in the markets recently has seen brokers update their Australian stock conviction lists.

Bank of Queensland has kicked off the bank reporting season, with Macquarie, ANZ, NAB and Westpac to follow. Analysts discuss what they’re looking for.

Tabcorp beat most market expectations with a strong March quarter revenue result, brokers generally continuing to see value leading into the upcoming de-merger vote.